Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-22-027714
Filing Date
2022-02-28
Accepted
2022-02-28 09:27:22
Documents
5
Effectiveness Date
2022-02-28

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm227485d1_s8.htm S-8 65848
2 EXHIBIT 5.1 tm227485d1_ex5-1.htm EX-5.1 8657
3 EXHIBIT 23.1 tm227485d1_ex23-1.htm EX-23.1 2160
4 EX-FILING FEES tm227485d1_ex-filingfee.htm EX-FILING FEES 14424
5 GRAPHIC tm227485d1_ex5-1img001.jpg GRAPHIC 4123
  Complete submission text file 0001104659-22-027714.txt   98040
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263070 | Film No.: 22684385
SIC: 2834 Pharmaceutical Preparations